Parvovirus B-19 infections in pregnant women in day care facilities:: Health economic analysis of prohibition to employ seronegative women

被引:8
作者
Gaertner, B. [1 ]
Enders, M. [2 ]
Luft-Duchow, C.
Bocharov, G. [3 ]
Modorow, S. [4 ]
机构
[1] Univ Klinikum Homburg, Inst Virol, D-66421 Homburg, Germany
[2] Labor Prof Enders, Stuttgart, Germany
[3] Russian Acad Sci, Moscow, Russia
[4] Univ Regensburg, D-8400 Regensburg, Germany
关键词
pregnancy; fifth disease; stillbirth; miscarriage; health economics;
D O I
10.1007/s00103-007-0367-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
German protective legislation during pregnancy and maternity prohibit employing pregnant women if occupational activities endanger the health of either the mother-to-be or the fetus. This applies for parvovirus B19 seronegative women caring for children <6 years. Here we present a cost-effectiveness analysis from the view of the society for the prohibition to employ B19-seronegative women in day care. Prohibition of employment starting at the first day of pregnancy may prevent 1.4 cases of fetal death (mortality) and 1.7 cases of hydrops fetalis (morbidity) per year resulting in costs of 30 million (SIC) (22 million (SIC)/live birth). The incidence of 1319 infection, the elevated occupational risk and the fetal death rate were varied in sensitivity analyses. This resulted in 0.2-3.1 fetal deaths prevented per year and costs between 10 million E and 150 million E per live birth. Indeed, the protective effect is assumed to be even lower since 30% of fetal deaths occur after infection during the first 8 weeks of pregnancy. During that time prohibition of employment is often unrealistic since the majority of women are not aware of pregnancy. in conclusion a small number of fetal lives can be saved by prohibiting employment in contrast to the extremely high costs. The regulations for maternal protection should be revised.
引用
收藏
页码:1369 / 1378
页数:10
相关论文
共 26 条
[1]   Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland [J].
Alanen, A ;
Kahala, K ;
Vahlberg, T ;
Koskela, P ;
Vainionpää, R .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2005, 112 (01) :50-56
[2]   PARVOVIRUS B19 INFECTION IN-HOSPITAL WORKERS - COMMUNITY OR HOSPITAL ACQUISITION [J].
DOWELL, SF ;
TOROK, TJ ;
THORP, JA ;
HEDRICK, J ;
ERDMAN, DD ;
ZAKI, SR ;
HINKLE, CJ ;
BAYER, WL ;
ANDERSON, LJ .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (04) :1076-1079
[3]  
Drummond MF, 2005, METHODS EC EVALUATIO
[4]  
ENDERS G, 2002, VARICELLA ZOSTER VIR, P317
[5]   Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases [J].
Enders, M ;
Weidner, A ;
Zoellner, I ;
Searle, K ;
Enders, G .
PRENATAL DIAGNOSIS, 2004, 24 (07) :513-518
[6]  
ENDERS M, COMMUNICATION
[7]   Economic implications of assisted reproductive techniques: a systematic review [J].
Garceau, L ;
Henderson, J ;
Davis, LJ ;
Petrou, S ;
Henderson, LR ;
McVeigh, E ;
Barlow, DH ;
Davidson, LL .
HUMAN REPRODUCTION, 2002, 17 (12) :3090-3109
[8]  
GARTNER BC, 2007, COST EFFECTIVE UNPUB
[9]   Seroprevalence of parvovirus B19 infection in daycare educators [J].
Gilbert, NL ;
Gyorkos, TW ;
Béliveau, C ;
Rahme, E ;
Muecke, C ;
Soto, JC .
EPIDEMIOLOGY AND INFECTION, 2005, 133 (02) :299-304
[10]   THE INCIDENCE OF HUMAN PARVOVIRUS B19 INFECTION DURING PREGNANCY AND ITS IMPACT ON PERINATAL OUTCOME [J].
GRATACOS, E ;
TORRES, PJ ;
VIDAL, J ;
ANTOLIN, E ;
COSTA, J ;
DEANTA, MTJ ;
CARARACH, V ;
ALONSO, PL ;
FORTUNY, A .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1360-1363